54321. Will I mean start.
Good afternoon ladies and gentlemen. On behalf of the board of Directors of Symbol Formulations India Limited, I company Secretary and Compliance officer of the company extend a very warm welcome to all the esteemed shareholders, board members, auditors, and who have joined us today for the 37th annual January meeting of the company.
I have been informed by the CDSL that the requisite quorum is present and accordingly with the kind permission of the chairman, we may commence the proceeding of this meeting. We are grateful for your continued trust, support, and encouragement, which has been a constant source of strength for us.
Their shared owners, Alex and friends, emotional movement as I stepped down as chairman of simple. Together we began with a small idea and built it into a company's serving millions. Thanks to your trust and your team's hard work, our values.
I have always been clear, affordable medicine, high quality and trust. I am proud to our achievement and reputation for integration and care.
Today I passed leadership to Mr. who presents the new dynamic generation that share our values. To our new chairman, I afford my full support.
And best wishes. Lead with clarity and purpose, and don't forget that is to serve people. I trust you to guide the company to greater heights. Although my time.
As chairman is over, I will still serve on the board and support. Thank you to everyone who joined me on this journey. Our success was only possible because of all of you. Is my dream and pride. I.
Hand it over with confidence and joy believing the best is yet to come. Thank you very much. Thank you all of you. Thank you. Thank you sir, for your inspiring words. Your vision, leadership, and dedication transforms income from its early foundation to the respective pharmaceutical compan.
Sir, your contribution and bessings will always remain the source of inspiration for us. On behalf of the board management and shareholders, I once again place on record our deep appreciation for your invaluable contribution. With that it is my privilege to now invite our new chairman.
I have to assume charge and take this meeting forward. Good afternoon everyone. Allow me to introduce myself. I'm Ankit Albankrua and as many of you know, I have the privilege of serving simong formulations as chief financial officer over the past eleven years.
Today I'm deeply honored to take on the role of chairman of this esteemed company. Having been part of journey and familiar with our strengths challenges and the values that have guided us from the very beginning. I carry this responsibility with strong sense of commitment, humility and dedication.
Now as the chairman, it gives me immense pleasure to welcome you all to the 37th annual general meeting of Singcom populations. Your presence today, whether in person or virtually reflects your ongoing commitment and believe in our company vision.
Strategy and I extend my heartbelt greetings to each one of you. At this outset I wish to express my sincere gratitude to our founder and former chairman. Your vision, perseverance, and values have shaped some symcomb into the trusted pharmaceutical company.
It is today. Serving millions of lights, I accept this responsibility with the commitment to carry forward the company with the same dedication and spirit. As the necessary forum is in place, I hear by declared the meeting open. Thank you sir. Dear shareholders.
As we are aware, this meeting is being held through video conferencing in accordance with the circulars issued by the Ministry of Corporate Affairs and Savi without the physical presence of the member at the venue of the meeting. Your company is having total six directors at present out of which two directors are attending meeting from the corporate office at Indoor and one.
Some director is attending meeting from Mumbai office, whereas the chairman of audit committee and SRC and the other two independent directors from their own location through video conference. All the directors are present at the meeting. Our study to the auditor, secretarial auditor and scrutinizer have also joined from their respective locations.
I would like to request the company to take role call of the directors. Thank you. I'm Ankit will chairman, and director, attending this meeting from.
I feel pleasure in welcoming you all at the 37th annual general meeting of your company. Now you, now I would like to request other directors to introduce themselves and start the role call starting from our managing director. Over to you respected managing director of the company.
All the directors are present at the meeting. Our request the.
Vijay.
I extended my best research to our stakeholders and look forward to discussion. Over to you, Director of the company.
Thank you. Good afternoon everyone. I am Kedarma full time director of attending this meeting from indoor. It's a pleasure to be here and I look forward to today's discussion. Over to Ruchi.
Thank you sir. Good afternoon, everyone. I'm Ruchi Independent Woman Director of Populations, and I'm attending this meeting from. It's my honor to participate in 37th AGM of our company. Thank you.
Yeah.
Thank you so much.
Good afternoon. I'm Independent Director of Formulations attending this I look forward to during this meeting. Over to you please.
I think due to some technical issues Ritesh is not here with us, so I would request to continue with the proceedings. Thank you all and my fellow director I would like to take a moment to welcome the other key participants in this agent mr. Manish with the statutory auditor of the company.
Mr. DK of the company. Mr. scrutinizer for the remote e voting and e voting at this year. Mr. Vijay.
We welcome mr. Rahul sir, as the new chief financial officer of the company formulations. He has been associated with the company's management functions and has constantly demonstrated dedication, problem solving, ability and leadership qualities.
With his deep involvement in the organizational process, progress, given he is well placed to strengthen the finance function in the alignment with our vision for sustainable growth. We extend our best wishes to him in his new responsibility.
I now hand over to our company security to guide us through the procedural aspects of the today's meeting. Thank you chairman, sir. Before we proceed, I would like to share few important instructions with our shareholders to ensure a smooth and uninterrupted experience. Shareholders are requested to join.
In the AGM using a laptop or IP iPad for optimal video and audio quality. For a stable connection, we recommend using Wi Fi online network instead of mobile hotspots. Please note participants connecting via mobile devices may face audio video disruptions due to network interruptions. All attendees are on mute by default to avoid background disturbance, only those shareholders who have party.
Participated as speakers will be unmuted during question and answer session. If you have not already voted through remote e voting, you may cast your votes via e voting facility during the meeting. I request to our new chairman sir to reach the chairman speech now. Respective shareholders, board members, colleagues, stakeholders.
Consultant and dear friends. A very good afternoon to all the board members and the renewable shareholders of the company present in the meeting through video conferencing. Now, as your new chairman, give me image pleasure to welcome you all to the 37th annual general meeting off.
Your presence today, whether in person or virtually reflect your ongoing commitment and believe in our company's vision and strategy. And I extend my heartfelt to each one of you. For me, leadership is not about position. It is about the trust.
The field of our shareholders, employees, regulators, partners, and customers will guide every decision I take. Looking ahead, my focus will remain clear. The 1st strengthening comp presence in both domestic and global markets.
Second driving innovation and growth across formulation, neutraceotical and new healthcare segments. 3rd up, upholding transparency compliance, and governance. Ensuring that shareholders confidence remain our strongest asset.
And lastly, and the most importantly, staying true to our purpose, delivering affordable, high quality medicine that positive impact lives. I take this role not just as a professional milestone.
But as a personal commitment, I invite you to judge me, not by my words today, but by the results we achieved together in the years to come. Looking back at the last past year, I'm proud that has continued to grow guided by a clear strategy.
And the focus on innovation. The pharmaceutical industry is a vital to health care. Creating medicines that improve and saved lives. It is challenging field with strict regulations, long term development timelines.
And constant drive to discover better solution. Today, I would like to take this opportunity to review the company's performance over the last financial year. Share our strategic vision of the future and highlight the steps we are taking to ensure continues.
To strengthen its position in the pharmaceutical industry. Company's performance over the last financial year. For the financial year 2020 04:25, Sinkong delivered an extraordinary performance over the last financial with revenue nearly doubling to release 4802 corrows.
From 2707 last year and profit after that's nearly doubling to around 50000. This outstanding achievement reflects the unwavering dedication of our team, the strength of our product portfolio and the continued trust and support of our shareholders.
Strategies, initiatives and future growth. Looking ahead, is focused on sustaining growth and strengthening its position in the pharmaceutical industry. While expanding into wellness.
Traditional healthcare through one of our fastest growing segments. Key focus, key areas of focus include expand expanding manufacturing capabilities, scaling facilities, including our injectable plans to meet growth to meet growing domestic and global demands.
Innovation and product portfolio expansion, developing new formulations specialized injectables, neutraceoticals and products to address evolving healthcare needs. Quality and compliance. Maintaining the highest regulatory standards through rigorous quality checks and global.
Inspections, market growth and initiatives, exploring new domestic and international markets by enhancing our presence in high demand segments such as OTC, wellness, nutrition and higher weather essence.
Marketing and branding strength. Targeted marketing, global visibility and strategy partnership, participating in IFX 2025, showcasing our products to international buyers by campaigning for iotgage distance.
Credibility in the market. We believe that by investing in brand development alongside operational efficiencies, Simon can enhance it market leadership and deliver great values to both customers and share them.
Corporate governance and investored relationships. At Samecomb we believe that strong government governance is not nearly regulatory requirements but the very foundation of sustainable growth. We have continued to strengthen our framework of transparency, accountability, and ethical conduction.
The board, the board remains fully compliant with CV regulations and compliance at 2013 requirements. We have well structured committees including audit, nomination, and remuneration, stakeholders relationship, CSR, and risk management.
And ensure ensuring oversight and longterm value creation. Independent directors have played a vital role in guiding management with objectivity and fairness. Today's investors are spread throughout the country.
And more than four like 71066 shareholders are part of the 99.73 share holders in demand more. CSR activity at our philosophy has been clear.
Giving back to the community. We strongly believe that while financial performance defines our success, our true purpose lies in creating a positive impact on people, communities, and the environment. The CSR initiative undertaken.
In 2020 04:25 is for education and skill development, that is scholarship, e learning support, and skill enhancement programs to empower youth and children as expanded an amount of approx 60.5 lakhs.
Compliance catributory obligations under section 01:35 of the 2030. Way for way forward going ahead, we will try to continue to focus on healthcare access, education for all and sustainability projects.
Our aim is to deepen our impact and create inclusive growth for both society and shareholders. Before concluding, I would like to express my sincere gratitude to our, to all our employees whose hard work and dedication had been instrumental to our success.
I would also like to thank our board of directors for their invaluable guidance and insight, as well as our esteemed shareholder for your unfavorable support. As we have, as we move into the new financial year I'm confident that is well equipped.
To navigate the challenge ahead and sees the opportunity that will further solidify our position in the global pharmaceutical next. Thank you once again for your trust, and I look forward to your continued partnership in the exciting journey that lies ahead.
To end, let me extend my gratitude to shareholders available at the AGM for sparing their valuable time today to join us for the annual general meeting. It is greatly appreciate. Now either I request to the members who has not voted.
Their votes to pass their votes through e voting, they can now vote in electronic mode by logging onto e voting India@the.com for agendas, items of notices for seeking your necessary approvals.
Thank you. Thank you sir. We are members electronic copies of the notice of AGM and the annual report for the financial year 2425 have been sent to all the members whose email address are registered with the company and or or.
Depository participants. The notice of the AGM can be found on pages seven to 22 of the annual report. I am pleased to inform you that the auditor's report provided by accountants contains NO qualifications or adverse remarks.
Dear shareholders, the studentizer for this meeting appointed by the board is mr. Anish Gukta, a company secretary in full time practice from Mumbai. He will ensure the e voting process is conducted fairly and transparently. I would like to inform you that the company has engaged central depository service.
Limited CDSL for remote e voting and e voting in this AGN and to facilitate this AGN to be conducted through video conferencing mode and as per the requirements of companies at 2030. The remote e voting was commenced from 26th of September at 09:00 A.M. and have already been completed on 28th.
September 05:00 P.M.. He voting at this AGM has already commenced and will be available up to 15 min from the conclusion of this AGM. Only shareholders on record as a cutoff date 22nd September are eligible to vote in this meeting. I would like to remind shareholders that person to the IEPF authority.
Those 2016, the company is in process to transfer the equity shares in respect of which the dividend has not been credited, has not been claimed for seven consecutive years to the investor education and protection fund of the central government.
The company has sent letters to the concerning shareholders whose dividend has not been claimed for seven consecutive years. The details of such shareholders are posted on the website of the company at www.sfile.in. Also individual regarding hundred days Campionesha.
From 28th July 2025 to 16th November 25, update your KYC today and claim your unpaid and unclaimed evidence has been given to the shareholders through newspaper publication and is also available on the website of the company at the www.sfile dot.
Coming back to our AGM proceedings, it may kindly be noted that any member who have already casted their vote by remote e voting shall not be entitled to vote again in this AGM. Now as per direction of the chairman survey, I would like to read the agenda item of the notice one by one, and I would like to request all the shareholders to please cast their.
If not done through remotely. The 1st item, the 1st item of ordinary business relates to receive consider and adopt the standalone and consolidated audited financial statement for the year 21st March 25 by ordinary resolution. Now coming over to the special business of the meeting.
2nd item of special business proposed to ratify the remederation paper to end goal and company cost accountants cost auditor for the financial year 2526 by passing ordinary resolution. The 3rd item of special business is to confirm the appointment of.
Passing company secretary as the secretary auditor of the company bypassing ordinary resolution. The 4th item of special business is to confirm the appointment of the director of the company bypassing ordinary resolution. The 5th item of special business is to confirm and approve the appointment of the executive chairman and full time director.
And to approve the remuneration paper to him by passing special resolution. The 6th item of special business is to approve the increase in the remunderation paper to mr. Raghu Vijay, chief financial officersuant to section 1881F of the Company's 2013 by passing ordinary resolution.
The seven item of special business is to confirm and approve the alteration and the articles of association of the company bypassing special resolution. The 8th item of special business is to confirm and approve the alteration in clause three A of memorandum of association of the company bypassing special resolution.
Now I would like to show a video session for the company. Now that the formal business of this meeting has been put forward with new approval of the chair, I invite all the members to view a brief video presentation featuring our latest advertisement, highlighting the new product offerings of the company.
We hope this week visual journey gives you some insights of the company's great products.
So.
This casey.
Now with the permission of the chairman sir, the floor is open for speakers to express their views or ask questions. Before we go live with the speaker session, here are some points to note. Kindly turn on your video when your name is called. You will be seen projected on the broadcast screen.
Unmute yourself and proceed to speak. We have already informed about the requirement of registering yourself as a speaker to express your views and ask questions during the agent. Adequate time was already provided for registration and NO query has been registered from any shareholders.
Please mention your name and location from where you are joining. Please be brief so that other shareholders also get a chance to participate in this section. Once you have already asked your question, you can turn your video off.
Mute yourself and continue to watch the procedures. I request to the moderator of the CDSL to call the name of the speakers one by one and unmute them.
Okay, we have received the list containing the some speaker shareholder. I'm taking the name one by one mr. 1st one mr. Narez Katchalia.
Okay.
Second one mr. Bimal Agrewan.
Is also not presenting this meeting.
Next one Kapil.
Last one mr. Gaurav Characya.
Ma'am there is NO speaker scheduler as present in the meeting.
Okay, as there are NO further questions and queries from the shareholders, however, any members still have certain queries can raise their queries through email and we will reply to them so quickly.
I would like to request the chairman sir, for concluding the meeting. Thank you to all speakers and shareholders for their participation. The result of the e voting along with the report will be announced within two working days and will be made available on the company's website as well as BASC, NSC and CTSL platforms.
Since all the business to be conducted at this AGN has been transacted, I have I hear by declared the 37th annual general meeting as close. I would like to thank all the shareholders for attending today's meeting. Stay healthy and stay safe. Thank you. Thank you.